Differential sensitivity to neuroleptic drugs of cerebral dopamine receptors following chronic treatment of rats with trifluoperazine.
D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects*; D002375:Catalepsy / Q000139:chemically induced; D005260:Female; D006220:Haloperidol / Q000032:analysis; D006801:Humans; D011869:Radioligand Assay; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects* / Q000378:metabolism; D013134:Spiperone / Q000378:metabolism; D013239:Stereotyped Behavior / Q000187:drug effects; D013764:Tetrahydronaphthalenes / Q000378:metabolism; D014268:Trifluoperazine / Q000494:pharmacology*
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D013764:Tetrahydronaphthalenes; D014268:Trifluoperazine; D013134:Spiperone; C011639:ADTN; D006220:Haloperidol